# Title

 Food and Drugs. PART 630â€”REQUIREMENTS FOR BLOOD AND BLOOD COMPONENTS INTENDED FOR TRANSFUSION OR FOR FURTHER MANUFACTURING USE


# ID

 CFR-2018-title21-vol7.Pt. 630


# Structured Analysis Summary

| Type        | Values                                                                                                                                                                                            |
|:------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Money       | [(175.0, 'GBP'), (110.0, 'GBP')]                                                                                                                                                                  |
| Constraints | ['no earlier than', 'before', 'more than', 'within', 'equal to', 'greater than', 'less than', 'after', 'minimum', 'exceed', 'no less than', 'prior to', 'minimum of', 'at least', 'no more than'] |
| Duration    | ['1.0 year', '24.0 hour', '12.0 month', '6.0 week', '72.0 hour', '4.0 week', '16.0 week', '2.0 day', '6.0 month', '3.0 week', '8.0 week', '1 day', '1.0 week']                                    |
| Condition   | ['provided that', 'where', 'if', 'when', 'unless']                                                                                                                                                |
| Entities    | ['Donor', 'Blood', 'Malaria', 'Food', 'Physician', 'Certain', 'Research', 'Information', 'B, and C', 'Donation', 'Purpose', 'Freedom', 'Medical', 'Male']                                         |


# Structured Analysis With Context

 


## Money

| Money          | Context                                                                                                                                          |
|:---------------|:-------------------------------------------------------------------------------------------------------------------------------------------------|
| (175.0, 'GBP') | (e) Infrequent plasma donor means a donor who has:                                                                                               |
|                |               (1) Not donated plasma by plasmapheresis or a co-collection of plasma with another blood component in the preceding 4 weeks; and   |
|                |               (2) Not donated more than 12.0 liters of plasma (14.4 liters of plasma for donors weighing more than 175 pounds) in the past year. |
| (110.0, 'GBP') | The donor must weigh a minimum of 50 kilograms (110 pounds).                                                                                     |


## Constraints

| Constraints     | Context                                                                                                                                                                |
|:----------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| minimum         | 610.41 of this chapter, is to provide certain minimum criteria for each donation of blood and blood                                                                    |
| more than       | the preceding 4 weeks; and (2) Not donated more than 12.0 liters of plasma (14.4 liters of plasma                                                                      |
| more than       | the preceding 4 weeks; and (2) Not donated more than 12.0 liters of plasma (14.4 liters of plasma                                                                      |
| before          | Medical history, physical examination, informed consent, and examination before  immunization.                                                                         |
| before          | components, must not collect blood or blood components before determining that the donor is eligible to donate                                                         |
| before          | components, must not collect blood or blood components before determining that the donor is eligible to donate                                                         |
| before          | educational material must you provide to the donor before  determining eligibility?                                                                                    |
| before          | educational material concerning relevant transfusion-transmitted infections to donors before donation when donor education about that relevant transfusion-transmitted |
| before          | donor eligibility on the day of donation, and before  collection.                                                                                                      |
| more than       | donating blood components that cannot be stored for more than 24 hours, you may determine the donor's eligibility                                                      |
| no earlier than | for testing required under &#167;&#8201;610.40 of this chapter, no earlier than 2 calendar days before the day of donation,                                            |
| before          | this chapter, no earlier than 2 calendar days before the day of donation, provided that your standard                                                                  |
| before          | that a donor's responses to the donor questions before collection were incomplete, within 24 hours of the                                                              |
| within          | to the donor questions before collection were incomplete, within 24 hours of the time of collection, you                                                               |
| before          | You must determine the donor's eligibility  before collection of blood or blood components, by the                                                                     |
| prior to        | collection site, you must consult the cumulative record prior to release of any blood or blood component prepared                                                      |
| before          | product manufactured from the blood or blood components. before                                                                                                        |
| within          | occurred; (v) Pregnancy at the time of, or within 6 weeks prior to, donation; (vi) Whether, in                                                                         |
| prior to        | at the time of, or within 6 weeks prior to , donation; (vi) Whether, in the opinion of                                                                                 |
| before          | must determine on the day of donation, and before collection that the donor is in good health                                                                          |
| exceed          | The donor's oral body temperature must not  exceed 37.5 &#176;C (99.5 &#176;F), or the equivalent if                                                                   |
| minimum         | The following  minimum  standards apply.                                                                                                                               |
| equal to        | donors must have a hemoglobin level that is equal to or greater than 12.5 grams of hemoglobin per                                                                      |
| greater than    | a hemoglobin level that is equal to or greater than 12.5 grams of hemoglobin per deciliter of blood,                                                                   |
| equal to        | donors must have a hemoglobin level that is equal to or greater than 12.5 grams of hemoglobin per                                                                      |
| greater than    | a hemoglobin level that is equal to or greater than 12.5 grams of hemoglobin per deciliter of blood,                                                                   |
| within          | Recognizing that lower levels are also  within normal limits for female donors, you may collect                                                                        |
| equal to        | donors must have a hemoglobin level that is equal to or greater than 13.0 grams of hemoglobin per                                                                      |
| greater than    | a hemoglobin level that is equal to or greater than 13.0 grams of hemoglobin per deciliter of blood,                                                                   |
| equal to        | donors must have a hemoglobin level that is equal to or greater than 13.0 grams of hemoglobin per                                                                      |
| greater than    | a hemoglobin level that is equal to or greater than 13.0 grams of hemoglobin per deciliter of blood,                                                                   |
| no less than    | An autologous donor must have a hemoglobin level no less than 11.0 grams of hemoglobin per deciliter of blood,                                                         |
| no less than    | An autologous donor must have a hemoglobin level no less than 11.0 grams of hemoglobin per deciliter of blood,                                                         |
| minimum of      | The donor must weigh a  minimum of  50 kilograms (110 pounds).                                                                                                         |
| after           | the donor may be contacted for 8 weeks after  donation; and                                                                                                            |
|                 |               (2) Donor's acknowledgement.                                                                                                                             |
| prior to        | acknowledgement that the donor has reviewed the information. prior to                                                                                                  |
| minimum         | It must, at a  minimum clearly address the following: (A) The donor has                                                                                                |
| prior to        | components from a donor found to be ineligible prior to collection based on criteria in &#167;&#167;&#8201;630.10 or 630.15,                                           |
| no more than    | Cells collected by apheresis, donation frequency must be no more than once in 8 weeks, and for apheresis collections                                                   |
| more than       | collected by apheresis, donation frequency must be no more than once in 8 weeks, and for apheresis collections                                                         |
| no more than    | on the day of the first donation or no more than 1 week before the first donation and at                                                                               |
| before          | first donation or no more than 1 week before the first donation and at subsequent intervals of                                                                         |
| no more than    | donor on the first day of donation or no more than 1 week before the first donation, and at                                                                            |
| before          | of donation or no more than 1 week before the first donation, and at subsequent intervals of                                                                           |
| within          | of a plasma donor who does not return within  6 months of the last donation.                                                                                           |
| before          | must determine the donor's total plasma protein level before  each plasmapheresis procedure.                                                                           |
| no less than    | must have a total plasma protein level of no less than 6.0 grams per deciliter and no more than                                                                        |
| no more than    | no less than 6.0 grams per deciliter and no more than 9.0 grams per deciliter in a plasma sample                                                                       |
| before          | (5) Examination  before  immunization.                                                                                                                                 |
| no more than    | assessing the general donor eligibility requirements under &#167;&#8201;630.10. no more than                                                                           |
| before          | (i) No more than 1 week  before the first immunization injection for the production of                                                                                 |
| within          | section, if the immunized donor's plasma is collected within  3 weeks of the first immunization injection.                                                             |
| after           | However, you may collect plasma by plasmapheresis  after a donation of Whole Blood or a single                                                                         |
| after           | However, you may collect plasma by plasmapheresis  after a donation of Whole Blood or a single                                                                         |
| at least        | unit of Red Blood Cells by apheresis after at least 2 calendar days have passed, provided that the                                                                     |
| less than       | the extracorporeal volume of the apheresis device is less than  100 milliliters.                                                                                       |
| less than       | The extracorporeal volume of the apheresis device is less than  100 milliliters.                                                                                       |
| no less than    | donor's physician, the donor has a hemoglobin level no less than 11.0 grams of hemoglobin per deciliter of blood                                                       |
| no less than    | donor's physician, the donor has a hemoglobin level no less than 11.0 grams of hemoglobin per deciliter of blood                                                       |
| prior to        | further testing required under &#167;&#8201;610.40(e) of this chapter prior to  notifying a donor of the deferral.                                                     |
| prior to        | If notification occurs  prior to receipt of such results, you must also notify                                                                                         |
| within          | must make reasonable attempts to notify the donor within 8 weeks after determining that the donor is                                                                   |
| after           | attempts to notify the donor within 8 weeks after determining that the donor is deferred or determined                                                                 |
| within          | attempts to notify the autologous donor's referring physician within 8 weeks after determining that the autologous donor                                               |
| after           | the autologous donor's referring physician within 8 weeks after determining that the autologous donor is deferred as                                                   |


## Duration

| Duration   | Context                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-----------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.0 week   | (e) Infrequent plasma donor means a donor who has:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |               (1) Not donated plasma by plasmapheresis or a co-collection of plasma with another blood component in the preceding 4 weeks; and                                                                                                                                                                                                                                                                                                                                                                                       |
|            |               (2) Not donated more than 12.0 liters of plasma (14.4 liters of plasma for donors weighing more than 175 pounds) in the past year.                                                                                                                                                                                                                                                                                                                                                                                     |
| 24.0 hour  | Except:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|            |               (1) When a donor is donating blood components that cannot be stored for more than 24 hours, you may determine the donor's eligibility and collect a sample for testing required under &#167;&#8201;610.40 of this chapter, no earlier than 2 calendar days before the day of donation, provided that your standard operating procedures address these activities.                                                                                                                                                      |
| 2.0 day    | Except:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
|            |               (1) When a donor is donating blood components that cannot be stored for more than 24 hours, you may determine the donor's eligibility and collect a sample for testing required under &#167;&#8201;610.40 of this chapter, no earlier than 2 calendar days before the day of donation, provided that your standard operating procedures address these activities.                                                                                                                                                      |
| 24.0 hour  | (2) In the event that, upon review, you find that a donor's responses to the donor questions before collection were incomplete, within 24 hours of the time of collection, you may clarify a donor's response or obtain omitted information required under paragraph (e) of this section, provided that your standard operating procedures address these activities.                                                                                                                                                                 |
| 72.0 hour  | (iv) Institutionalization for 72 hours or more consecutively in the past 12 months in a correctional institution;                                                                                                                                                                                                                                                                                                                                                                                                                    |
|            |               (v) Intimate contact with risk for a relevant transfusion-transmitted infection; and                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |               (vi) Nonsterile percutaneous inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 12.0 month | (iv) Institutionalization for 72 hours or more consecutively in the past 12 months in a correctional institution;                                                                                                                                                                                                                                                                                                                                                                                                                    |
|            |               (v) Intimate contact with risk for a relevant transfusion-transmitted infection; and                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|            |               (vi) Nonsterile percutaneous inoculation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 6.0 week   | Your assessment of the donor must include each of the following factors:                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|            |               (i) Symptoms of a recent or current illness;                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|            |               (ii) Certain medical treatments or medications;                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|            |               (iii) Travel to, or residence in, an area endemic for a transfusion-transmitted infection, when such screening is necessary to assure the safety, purity, and potency of blood and blood components due to the risks presented by donor travel and the risk of transmission of that transfusion-transmitted infection by such donors;                                                                                                                                                                                  |
|            |               (iv) Exposure or possible exposure to an accidentally or intentionally released disease or disease agent relating to a transfusion-transmitted infection, if you know or suspect that such a release has occurred;                                                                                                                                                                                                                                                                                                     |
|            |               (v) Pregnancy at the time of, or within 6 weeks prior to, donation;                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|            |               (vi) Whether, in the opinion of the interviewer, the donor appears to be under the influence of any drug, alcohol or for any reason does not appear to be providing reliable answers to medical history questions, or if the donor says that the purpose of donating is to obtain test results for a relevant transfusion-transmitted infection; and                                                                                                                                                                   |
|            |               (vii) The donor is a xenotransplantation product recipient.                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 8.0 week   | You must obtain proof of identity of the donor and a postal address where the donor may be contacted for 8 weeks after donation; and                                                                                                                                                                                                                                                                                                                                                                                                 |
|            |               (2) Donor's acknowledgement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 8.0 week   | (i) For a collection resulting in a single unit of Whole Blood or Red Blood Cells collected by apheresis, donation frequency must be no more than once in 8 weeks, and for apheresis collections resulting in two units of Red Blood Cells, the donor must not donate more than once in 16 weeks.                                                                                                                                                                                                                                    |
| 16.0 week  | (i) For a collection resulting in a single unit of Whole Blood or Red Blood Cells collected by apheresis, donation frequency must be no more than once in 8 weeks, and for apheresis collections resulting in two units of Red Blood Cells, the donor must not donate more than once in 16 weeks.                                                                                                                                                                                                                                    |
| 8.0 week   | When a donor who is determined to be eligible under &#167;&#8201;630.10 undergoes a therapeutic phlebotomy under a prescription to promote the donor's health, you may collect from the donor more frequently than once in 8 weeks for collections resulting in a single unit of Whole Blood or Red Blood Cells, or once in 16 weeks for apheresis collections resulting in two units of Red Blood Cells, provided that the container label conspicuously states the disease or condition of the donor that necessitated phlebotomy. |
| 16.0 week  | When a donor who is determined to be eligible under &#167;&#8201;630.10 undergoes a therapeutic phlebotomy under a prescription to promote the donor's health, you may collect from the donor more frequently than once in 8 weeks for collections resulting in a single unit of Whole Blood or Red Blood Cells, or once in 16 weeks for apheresis collections resulting in two units of Red Blood Cells, provided that the container label conspicuously states the disease or condition of the donor that necessitated phlebotomy. |
| 1.0 week   | Except as provided in &#167;&#8201;630.25:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|            |               (i) The responsible physician must conduct an appropriate medical history and physical examination of the donor on the day of the first donation or no more than 1 week before the first donation and at subsequent intervals of no longer than 1 year.                                                                                                                                                                                                                                                                |
| 1.0 year   | Except as provided in &#167;&#8201;630.25:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
|            |               (i) The responsible physician must conduct an appropriate medical history and physical examination of the donor on the day of the first donation or no more than 1 week before the first donation and at subsequent intervals of no longer than 1 year.                                                                                                                                                                                                                                                                |
| 6.0 month  | (iii) The responsible physician must conduct a new medical history and physical examination of a donor who does not return for 6 months.                                                                                                                                                                                                                                                                                                                                                                                             |
| 1 day      | (i) The responsible physician must obtain the informed consent of a plasma donor on the first day of donation or no more than 1 week before the first donation, and at subsequent intervals of no longer than 1 year.                                                                                                                                                                                                                                                                                                                |
| 1.0 week   | (i) The responsible physician must obtain the informed consent of a plasma donor on the first day of donation or no more than 1 week before the first donation, and at subsequent intervals of no longer than 1 year.                                                                                                                                                                                                                                                                                                                |
| 1.0 year   | (i) The responsible physician must obtain the informed consent of a plasma donor on the first day of donation or no more than 1 week before the first donation, and at subsequent intervals of no longer than 1 year.                                                                                                                                                                                                                                                                                                                |
| 6.0 month  | (ii) The responsible physician must obtain the informed consent of a plasma donor who does not return within 6 months of the last donation.                                                                                                                                                                                                                                                                                                                                                                                          |
| 1.0 week   | (i) No more than 1 week before the first immunization injection for the production of high-titer antibody plasma, the responsible physician must conduct an appropriate medical history and physical examination, as described in paragraph (b)(1) of this section, in addition to assessing the general donor eligibility requirements under &#167;&#8201;630.10.                                                                                                                                                                   |
| 3.0 week   | It is not necessary to repeat the medical history and physical examination requirement in paragraph (b)(1) of this section, if the immunized donor's plasma is collected within 3 weeks of the first immunization injection.                                                                                                                                                                                                                                                                                                         |
| 8.0 week   | (i) You must defer a donor from donating plasma by plasmapheresis for 8 weeks if the donor has donated a unit of Whole Blood, or a single unit of Red Blood Cells by apheresis.                                                                                                                                                                                                                                                                                                                                                      |
| 2.0 day    | However, you may collect plasma by plasmapheresis after a donation of Whole Blood or a single unit of Red Blood Cells by apheresis after at least 2 calendar days have passed, provided that the extracorporeal volume of the apheresis device is less than 100 milliliters.                                                                                                                                                                                                                                                         |
| 16.0 week  | (ii) You must defer a donor from donating plasma by plasmapheresis for a period of 16 weeks if the donor donates two units of Red Blood Cells during a single apheresis procedure;                                                                                                                                                                                                                                                                                                                                                   |
|            |               (iii) You must defer a donor for 8 weeks or more if the cumulative red blood cell loss in any 8 week period could adversely affect donor health.                                                                                                                                                                                                                                                                                                                                                                       |
| 8.0 week   | (ii) You must defer a donor from donating plasma by plasmapheresis for a period of 16 weeks if the donor donates two units of Red Blood Cells during a single apheresis procedure;                                                                                                                                                                                                                                                                                                                                                   |
|            |               (iii) You must defer a donor for 8 weeks or more if the cumulative red blood cell loss in any 8 week period could adversely affect donor health.                                                                                                                                                                                                                                                                                                                                                                       |
| 8.0 week   | (ii) You must defer a donor from donating plasma by plasmapheresis for a period of 16 weeks if the donor donates two units of Red Blood Cells during a single apheresis procedure;                                                                                                                                                                                                                                                                                                                                                   |
|            |               (iii) You must defer a donor for 8 weeks or more if the cumulative red blood cell loss in any 8 week period could adversely affect donor health.                                                                                                                                                                                                                                                                                                                                                                       |
| 8.0 week   | You must make reasonable attempts to notify the donor within 8 weeks after determining that the donor is deferred or determined not to be eligible for donation as described in paragraph (a) of this section.                                                                                                                                                                                                                                                                                                                       |
| 8.0 week   | (2) You must make reasonable attempts to notify the autologous donor's referring physician within 8 weeks after determining that the autologous donor is deferred as described in paragraph (a) of this section.                                                                                                                                                                                                                                                                                                                     |


## Condition

| Condition     | Context                                                                                                                                                           |
|:--------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| where         | as a health care worker in the jurisdiction where the collection establishment is located; (3) Currently certified                                                |
| when          | and authorized under State law, and/or local law when applicable, to perform the specified functions under the                                                    |
| when          | not listed in paragraph (h)(1) of this section when the following conditions are met: (i) Appropriate screening                                                   |
| where         | (1) Licensed to practice medicine in the jurisdiction where the collection establishment is located; (2) Adequately trained                                       |
| when          | is authorized under State law, and/or local law when applicable, and adequately instructed and qualified to perform                                               |
| provided that | &#167;&#8201;640.21(g) of this chapter; or (v) Other activities provided that the Director, Center for Biologics Evaluation and Research,                         |
| when          | need not be present at the collection site when activities delegated under paragraph (b)(1) of this section                                                       |
| provided that | under paragraph (b)(1) of this section are performed, provided that the responsible physician has delegated oversight of these                                    |
| provided that | activities described in paragraph (c)(1)(i)(A) of this section, provided that the responsible physician or a physician substitute is                              |
| when          | physician, who may or may not be present when these activities are performed, may delegate to a                                                                   |
| provided that | to a donor in an approved collection program, provided that the responsible physician or a physician substitute is                                                |
| when          | is on the premises at the collection site when  the immunization is administered.                                                                                 |
| provided that | to a donor in an approved collection program, provided that the responsible physician has approved the procedure and                                              |
| when          | is on the premises at the collection site when  the red blood cells are administered.                                                                             |
| when          | required to be present at the collection site when  the physician substitute performs these activities under supervision.                                         |
| when          | need not be present at the collection site when any of these activities are performed, provided that                                                              |
| provided that | site when any of these activities are performed, provided that the responsible physician has delegated oversight of these                                         |
| when          | for obtaining rapid emergency medical services for donors when  medically necessary.                                                                              |
| if            | A donor is not eligible  if  the donor is not in good health or                                                                                                   |
| if            | A donor is not eligible  if  the donor is not in good health or                                                                                                   |
| when          | concerning relevant transfusion-transmitted infections to donors before donation when donor education about that relevant transfusion-transmitted infection, such |
| when          | donor not to donate blood and blood components when  a risk factor is present.                                                                                    |
| when          | must you determine the eligibility of a donor? when                                                                                                               |
| when          | that your standard operating procedures address these activities. when                                                                                            |
| provided that | 2 calendar days before the day of donation, provided that  your standard operating procedures address these activities.                                           |
| provided that | information required under paragraph (e) of this section, provided that  your standard operating procedures address these activities.                             |
| if            | blood or blood component prepared from the collection. if                                                                                                         |
| if            | interview as described in this section to determine if  the donor is in good health; to ident                                                                     |
| if            | interview as described in this section to determine if  the donor is in good health; to ident                                                                     |
| when          | A donor is ineligible to donate  when information provided by the donor or other reliable                                                                         |
| if            | indicates possible exposure to a relevant transfusion-transmitted infection if that risk of exposure is still applicable at                                       |
| when          | A donor is ineligible to donate  when donating could adversely affect the health of the                                                                           |
| when          | A donor is ineligible to donate  when donating could adversely affect the health of the                                                                           |
| when          | in, an area endemic for a transfusion-transmitted infection, when such screening is necessary to assure the safety,                                               |
| if            | or disease agent relating to a transfusion-transmitted infection, if you know or suspect that such a release                                                      |
| if            | or disease agent relating to a transfusion-transmitted infection, if you know or suspect that such a release                                                      |
| if            | exceed 37.5 &#176;C (99.5 &#176;F), or the equivalent if  measured at another body site;                                                                          |
|               |               (2) Blood pressure.                                                                                                                                 |
| when          | these limits may be permitted to donate only when the responsible physician examines the donor and determines                                                     |
| provided that | a hematocrit value between 36 and 38 percent, provided that you have taken additional steps to assure that                                                        |
| when          | these limits may be permitted to donate only when the responsible physician determines and documents that the                                                     |
| where         | identity of the donor and a postal address where the donor may be contacted for 8 weeks                                                                           |
| if            | infections; (B) The donor agrees not to donate if the donation could result in a potential risk                                                                   |
| if            | infections; (B) The donor agrees not to donate if the donation could result in a potential risk                                                                   |
| if            | infections; (B) The donor agrees not to donate if the donation could result in a potential risk                                                                   |
| when          | (h) What must you do  when  a donor is not eligible?                                                                                                              |
| unless        | deferred under &#167;&#8201;610.41 of this chapter or &#167;&#8201;630.30(b)(2), unless  this subchapter provides an exception.                                   |
| when          | (a) What additional donor eligibility requirements apply  when you, an establishment that collects blood or blood                                                 |
| unless        | limitations in paragraph (a)(1)(i) of this section apply unless the responsible physician examines the donor at the                                               |
| provided that | resulting in two units of Red Blood Cells, provided that the container label conspicuously states the disease or                                                  |
| when          | Hereditary hemochromatosis; or (B) Another disease or condition, when the health of a donor with that disease                                                     |
| when          | (b) What additional donor eligibility requirements apply  when you, an establishment that collects blood or blood                                                 |
| if            | include the risks of a hemolytic transfusion reaction if the donor is given the cells of another                                                                  |
| if            | include the risks of a hemolytic transfusion reaction if the donor is given the cells of another                                                                  |
| if            | physician must again obtain an informed consent spec if ic for that program.                                                                                      |
| if            | examination requirement in paragraph (b)(1) of this section, if the immunized donor's plasma is collected within 3                                                |
| unless        | program and determined to be eligible under &#167;&#8201;630.10 unless the medical history and physical examination are due                                       |
| if            | from donating plasma by plasmapheresis for 8 weeks if the donor has donated a unit of Whole                                                                       |
| provided that | after at least 2 calendar days have passed, provided that the extracorporeal volume of the apheresis device is                                                    |
| if            | by plasmapheresis for a period of 16 weeks if the donor donates two units of Red Blood                                                                            |
| if            | by plasmapheresis for a period of 16 weeks if the donor donates two units of Red Blood                                                                            |
| if            | by plasmapheresis due to red blood cell loss if the following conditions are met: (i) The responsible                                                             |
| if            | any provision of &#167;&#8201;630.10(e) and (f) or &#167;&#8201;630.15(a) if one of the following sets of conditions are                                          |
| when          | (a) When is a donation suitable? when                                                                                                                             |
| unless        | of this chapter, and is negative or nonreactive, unless an exception applies under &#167;&#8201;610.40(h) of this chapter;                                        |
| when          | (b) What must you do  when  the donation is not suitable?                                                                                                         |
| unless        | the donation for transfusion or further manufacturing use unless it is an autologous donation, or an exception                                                    |
| when          | (2) You must defer the donor  when a donation is determined to be unsuitable based                                                                                |
| when          | must defer the donor of bacterially contaminated platelets when the contaminating organism is identified in accordance with                                       |
| if            | as a donor of blood and blood components if , at the time of the current collection,                                                                              |
| if            | for the previous deferral are no longer applicable if the following conditions are met: (a) The previous                                                          |
| where         | Where appropriate, information concerning medical followup and counseling. where                                                                                  |
| where         | Where appropriate, information concerning medical followup and counseling. where                                                                                  |
| where         | Where appropriate, information concerning medical followup and counseling. where                                                                                  |
| when          | that you have successfully notified the donor or when you are unsuccessful that you have made reasonable                                                          |
| where         | testing as required in &#167;&#8201;610.40(e) of this chapter. where                                                                                              |
| when          | successfully notified the autologous donor's referring physician or when you are unsuccessful that you have made reasonable                                       |


## Entities

| Entities    | Context                                                                                                                   |
|:------------|:--------------------------------------------------------------------------------------------------------------------------|
| Food        | Food  and Drugs.                                                                                                          |
| Purpose     | Purpose  and scope.                                                                                                       |
| B, and C    | (a) What is the purpose of subparts A,  B, and C  of this part?                                                           |
| B, and C    | (b) Who must comply with subparts A,  B, and C  of this part?                                                             |
| Blood       | Blood establishments that manufacture blood and blood components, as                                                      |
| B, and C    | &#167;&#8201;630.3(a) and (b), must comply with subparts A, B, and C  of this part.                                       |
| Physician   | (g)  Physician substitute means a trained and qualified person(s) who                                                     |
| Medical     | Medical  supervision.                                                                                                     |
| Research    | that the Director, Center for Biologics Evaluation and Research , determines that delegating the activities would present |
| Information | Information and evidence indicating possible exposure to a relevant                                                       |
| Certain     | Symptoms of a recent or current illness; (ii) Certain medical treatments or medications; (iii) Travel to, or              |
| Blood       | Blood  obtained from the earlobe is not acceptable.                                                                       |
| Male        | (B)  Male allogeneic donors must have a hemoglobin level that                                                             |
| Donor       | Donor eligibility requirements specific to Whole Blood, Red Blood                                                         |
| Malaria     | (8)  Malaria .                                                                                                            |
| Freedom     | Freedom from risk of malaria is not required for                                                                          |
| Research    | from the Director, Center for Biologics Evaluation and Research , to collect plasma for further manufacturing use         |
| Donation    | Donation  suitability requirements.                                                                                       |


